Close Menu
    What's Hot

    Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 17, 2026

    Athora To Sell German Business to Frankfurter Leben

    August 17, 2026

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      Talcott Financial Group, Goldman Sachs Launch West Grove Re

      August 5, 2026

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Regulatory Progress Has Boosted Life Settlements, Yet Education Remains Key to Growth

    Secondary Life Markets November 12, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    This month marks the 25th anniversary of the adoption of the National Council of Insurance Legislators’ (NCOIL) Life Settlements Model Act (LSMA) – one of the two model acts (the NAIC’s Viatical Settlements Model Act being the other) that determines the regulatory landscape of the life settlement industry’s secondary market. 

    Originally adopted on 17th November 2000, the LSMA was created to protect policyholders and sets regulatory criteria across a wide range of categories, from licensing requirements to prohibited practices, from disclosures to fraud prevention, from advertising to reporting requirements and much more. 

    While the LSMA is, by definition, a model act, with no actual legislative power, getting amendments to it is important for the life settlement market because standardising the regulatory environment reduces operational friction across states, reducing time and money costs, which can ultimately be redeployed into increasing the supply of eligible policies into the market. 

    Amendments are rare – only three times in the past two-plus decades, indeed – but the most recent update came in November last year (after being postponed twice, first in April and then in July, as negotiations between the life settlement market and the life insurance industry went back and forth about two proposed amendments from industry group the Life Insurance Settlement Association (LISA)).  

    The one that eventually passed relates to the requiring of insurers to accept electronic or facsimile requests for verification of coverage and to send confirmation of change of ownership or beneficiary via electronic means. Remarkably, some carriers in the market were – and still are, according to anecdotal evidence – using snail mail for certain document exchanges, and despite the fact that this may seem bewildering to those outside the life settlement market, the passing of the resolution will make a difference. 

    “The carriers provide different levels of cooperation. Some have no issue with e-signatures, but some are resistant. That’s partly because of the way they have always done things and partly because it’s life settlements,” said Alan Buerger, Co-Founder and Executive Chairman of Coventry (and who frequently represents LISA in negotiations with NCOIL and life insurance group the American Council of Life Insurers (ACLI)). 

    “We wanted to get carriers to operate more consistently, with good practices, regardless of their antipathy to life settlements.” 

    The other amendment didn’t pass, however. LISA didn’t get approval for its request to make it unlawful for an insurer to prohibit a life insurance producer or broker from disclosing to a client the availability of a life settlement contract. 

    “We made a judgement call that because we got agreement with the ACLI on the electronic communications issue, we could then say to NCOILs committee that the carriers agree, which made it more likely that the amendment would pass so we backed down on the prohibition issue. This was still absolutely a win for our industry,” said Buerger. 

    Bryan Nicholson, Executive Director at LISA, agrees. 

    “Transacting in the life settlement market is a complex process because of the substantial regulatory requirements attached to each transaction – which are designed to protect consumers. While it’s likely that the process will never be instant, that doesn’t mean that it can’t be improved. Over the years, many of our members have expressed frustration on behalf of the policyholder that the process was too lengthy, so we’re pleased that this amendment passed last time,” he said.  

    So, a win and a loss – for now – for the life settlement market in the most recent round of negotiations. But the industry has benefitted from other previous regulatory developments. 2007 was arguably a banner year for the life settlement market, for two reasons. 

    First were the amendments to the LSMA specifically to combat the growing practice of STOLI (Stranger-Originated Life Insurance). STOLI schemes involve life insurance origination with the primary intent of selling them for a profit, which regulators viewed at the time – and still do – as an attempt to circumvent insurable interest laws. 

    This amendment protected not only consumers and life insurers, but arguably the life settlement market itself, as litigation risk on insurable interest grounds fell, meaning that asset managers of life settlement portfolios and their clients – large institutional investors who demand legal certainty and predictable returns – received a greater degree of comfort. 

    Second was the amendment to allow licensed life insurance agents to obtain a separate license as a life settlement broker. For agents, this was beneficial because it allowed agents to better serve their clients by providing a crucial, valuable alternative to simply lapsing or surrendering a policy for low cash value and it created a new, regulated source of compensation for agents who help clients liquidate an asset they no longer need. Before the amendment, this path was often unclear or prohibited. 

    “The amendment to identify and prohibit STOLI was a significant development for the life settlement market because it tightened up the definition of STOLI so that it was clear not only what it was but just as importantly for us, what it wasn’t. It provided a lot of clarity for all participants in our market,” said Buerger. 

    “Although by far the most beneficial was the enabling of insurance agents or producers to advise their clients and get compensated for doing so with regards to life settlements. At the time, there were strong views on the part of the carriers and some participants in the industry to not allow this; it was the big fight at the time.” 

    While there is no rule that is set in stone with regards to when the LSMA will come up for re-adoption again, history tells us that it is every five years or so. That means the life settlement industry has four years to figure out what it wants to try and amend next time; the significant lag from model act change to state legislation enactment means that the e-signature amendment will have only recently been in full force to any significant extent (unless insurers decide to be pro-active, of course). 

    And while Buerger wants to revisit the recent knock-back with regards to the desire to make it unlawful for an insurer to prohibit a life insurance producer or broker from disclosing to a client the availability of a life settlement contract – “We will resurrect that,” he said – ultimately, securing beneficial regulatory change is only one pillar out of many that the life settlement market needs to influence in order to grow significantly. 

    “The thing that is most important is education. I’m pleased that the industry – providers, brokers, etc. – have been much more aggressive over the last several years in educating insurance marketing organisations, financial advisors, etc. There has been much more of a concerted effort among the participants,” he said. 

    “A large number of the players are very active digitally which has generated more consumer awareness. At the same time, we’re adversely affected as an industry when there is bad PR as a result of litigation or investors not doing as well as they would like or expect they should. Ours is an industry where it’s a pendulum; one side is the flow of capital, and the flip side is the flow of policies. In order to increase both we have to be relentless in educating our stakeholders, not just pushing for regulatory change.” 

    2025 - November Life Settlements Longevity Risk Volume 1 Issue 2 – November 2025
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.